Last reviewed · How we verify
NCT00149617
Career Training in Marijuana Dependence
Phase 2 trial testing Buspirone in Marijuana Abuse in 81 participants. Completed in 1 December 2007.
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 81 |
| Start date | 1 April 2004 |
| Estimated completion | 1 December 2007 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Buspirone (BUSPIRONE) — full drug profile →
Conditions studied
- Marijuana Abuse — all drugs for Marijuana Abuse →
- Mood Disorders — all drugs for Mood Disorders →
Sponsor
Medical University of South Carolina
Who can join
Adults 18 to 65, any sex, with Marijuana Abuse or Mood Disorders. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
- Drug use; measured at Weeks 12 and 16
Sponsor's own description
This study will assess the effectiveness of a combination of buspirone and motivational interviewing therapy in the treatment of marijuana dependence.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00149617
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Buspirone
Trials testing the same drug.
- NCT05511909 — Evaluating Buspirone to Treat Opioid Withdrawal · Phase 2 · active not recruiting
- NCT05430217 — Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accom · Phase 3 · completed
- NCT05377619 — Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial · Phase 1, PHASE2 · completed
- NCT04807517 — Buspirone Treatment of Anxiety in Williams Syndrome · Phase 4 · completed
- NCT05041322 — Improving Ventilatory Capacity in Those With Chronic High Level SCI · Phase 2 · completed
Other recruiting trials for Marijuana Abuse
Currently open trials in the same condition.
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00149617 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 8 October 2015
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00149617.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing